|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-5-1
|
|
pubmed:abstractText |
HER-2/neu oncogene encodes a transmembrane tyrosine kinase receptor that is amplified and/or overexpressed predominantly in adenocarcinomas. This phenomenon has been most intensively studied in breast carcinoma where its amplification and overexpression correlate with the overall course of disease and poor prognosis. This study was designed to investigate HER-2/neu gene expression in benign and malignant colorectal lesions and to evaluate its prognostic importance in colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
pubmed-author:Andelinovi?SS,
pubmed-author:Ferenci?ZZ,
pubmed-author:Kapitanovi?MM,
pubmed-author:Kapitanovi?SS,
pubmed-author:PavelicKK,
pubmed-author:Primora?DD,
pubmed-author:Radosevi?SS,
pubmed-author:SonickiZZ,
pubmed-author:SpaventiRR,
pubmed-author:SpaventiSS,
pubmed-author:TavassoliMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1103-13
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9097992-Adenocarcinoma,
pubmed-meshheading:9097992-Adenoma,
pubmed-meshheading:9097992-Colorectal Neoplasms,
pubmed-meshheading:9097992-Gene Expression,
pubmed-meshheading:9097992-Genes, erbB-2,
pubmed-meshheading:9097992-Humans,
pubmed-meshheading:9097992-Hyperplasia,
pubmed-meshheading:9097992-Neoplasm Metastasis,
pubmed-meshheading:9097992-Neoplasm Staging,
pubmed-meshheading:9097992-Polyps,
pubmed-meshheading:9097992-Precipitin Tests,
pubmed-meshheading:9097992-Regression Analysis,
pubmed-meshheading:9097992-Retrospective Studies,
pubmed-meshheading:9097992-Survival Analysis,
pubmed-meshheading:9097992-Time Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.
|
|
pubmed:affiliation |
Division of Molecular Medicine, Ruder Boskovi? Institute, Zagreb, Croatia.
|
|
pubmed:publicationType |
Journal Article
|
